Skip to content
Curr Med Res Opin.
In those cases it is necessary to gauge what kind of effect transitioning will have on their well-being.
Potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
This includes any possible side effects not listed in this leaflet.
In practice, this option may be most acceptable among women unconcerned about progestogenic adverse effects e.
About one third of women with endometriosis remain asymptomatic while some women with endometriosis have some degree of pelvic pain.
See also gender-disaffirming.
It is recommended that providers discuss these considerations with patients before initiation of hormones in order to make an informed decision.
Increased frequency of office visits may also be useful for patients with complex psychosocial situations to allow for the provision of ancillary or wraparound services.